These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The clinical impact of Pieters A; Bakker M; Hoek RAS; Altenburg J; van Westreenen M; Aerts JGJV; van der Eerden MM Eur Respir J; 2019 Apr; 53(4):. PubMed ID: 30635292 [No Abstract] [Full Text] [Related]
3. The effect of Pseudomonas aeruginosa infection on clinical parameters in steady-state bronchiectasis. Ho PL; Chan KN; Ip MS; Lam WK; Ho CS; Yuen KY; Tsang KW Chest; 1998 Dec; 114(6):1594-8. PubMed ID: 9872194 [TBL] [Abstract][Full Text] [Related]
4. Molecular epidemiological analysis suggests cross-infection with Pseudomonas aeruginosa is rare in non-cystic fibrosis bronchiectasis. De Soyza A; Perry A; Hall AJ; Sunny SS; Walton KE; Mustafa N; Turton J; Kenna DT; Winstanley C Eur Respir J; 2014 Mar; 43(3):900-3. PubMed ID: 24176999 [No Abstract] [Full Text] [Related]
5. Eradication of Blanco-Aparicio M; Saleta Canosa JL; Valiño López P; Martín Egaña MT; Vidal García I; Montero Martínez C Chron Respir Dis; 2019; 16():1479973119872513. PubMed ID: 31480862 [TBL] [Abstract][Full Text] [Related]
6. A novel microbiota stratification system predicts future exacerbations in bronchiectasis. Rogers GB; Zain NM; Bruce KD; Burr LD; Chen AC; Rivett DW; McGuckin MA; Serisier DJ Ann Am Thorac Soc; 2014 May; 11(4):496-503. PubMed ID: 24592925 [TBL] [Abstract][Full Text] [Related]
7. [Inhaled colistin in elderly patients with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa bronchial infection]. Tabernero Huguet E; Gil Alaña P; Alkiza Basañez R; Hernández Gil A; Garros Garay J; Artola Igarza JL Rev Esp Geriatr Gerontol; 2015; 50(3):111-5. PubMed ID: 25724860 [TBL] [Abstract][Full Text] [Related]
8. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis. Bilton D; Henig N; Morrissey B; Gotfried M Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030 [TBL] [Abstract][Full Text] [Related]
9. Macrolide Treatment Inhibits Pseudomonas aeruginosa Quorum Sensing in Non-Cystic Fibrosis Bronchiectasis. An Analysis from the Bronchiectasis and Low-Dose Erythromycin Study Trial. Burr LD; Rogers GB; Chen AC; Hamilton BR; Pool GF; Taylor SL; Venter D; Bowler SD; Biga S; McGuckin MA Ann Am Thorac Soc; 2016 Oct; 13(10):1697-1703. PubMed ID: 27464029 [TBL] [Abstract][Full Text] [Related]
10. Hilliam Y; Moore MP; Lamont IL; Bilton D; Haworth CS; Foweraker J; Walshaw MJ; Williams D; Fothergill JL; De Soyza A; Winstanley C Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28446558 [TBL] [Abstract][Full Text] [Related]
11. A Comprehensive Analysis of the Impact of Pseudomonas aeruginosa Colonization on Prognosis in Adult Bronchiectasis. Finch S; McDonnell MJ; Abo-Leyah H; Aliberti S; Chalmers JD Ann Am Thorac Soc; 2015 Nov; 12(11):1602-11. PubMed ID: 26356317 [TBL] [Abstract][Full Text] [Related]
12. Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection. VanDevanter DR; Gonda I; Dahms J; Cipolla D; Davis AM; Chalmers JD; Froehlich J Clin Microbiol Infect; 2019 Dec; 25(12):1532-1538. PubMed ID: 31035017 [TBL] [Abstract][Full Text] [Related]
13. Bronchiectasis with secondary pulmonary infection in a child: A case report. Zhu T; Gu H; Vinturache A; Ding G; Lu M Medicine (Baltimore); 2020 Sep; 99(39):e22475. PubMed ID: 32991486 [TBL] [Abstract][Full Text] [Related]
14. Chronic colonization by Pseudomonas aeruginosa of patients with obstructive lung diseases: cystic fibrosis, bronchiectasis, and chronic obstructive pulmonary disease. Valderrey AD; Pozuelo MJ; Jiménez PA; Maciá MD; Oliver A; Rotger R Diagn Microbiol Infect Dis; 2010 Sep; 68(1):20-7. PubMed ID: 20727465 [TBL] [Abstract][Full Text] [Related]
15. Transmission of bacteria in bronchiectasis and chronic obstructive pulmonary disease: Low burden of cough aerosols. Stockwell RE; Chin M; Johnson GR; Wood ME; Sherrard LJ; Ballard E; O'Rourke P; Ramsay KA; Kidd TJ; Jabbour N; Thomson RM; Knibbs LD; Morawska L; Bell SC Respirology; 2019 Oct; 24(10):980-987. PubMed ID: 30919511 [TBL] [Abstract][Full Text] [Related]
16. A Randomized Controlled Trial of Atorvastatin in Patients With Bronchiectasis Infected With Pseudomonas Aeruginosa: A Proof of Concept Study. Bedi P; Chalmers JD; Graham C; Clarke A; Donaldson S; Doherty C; Govan JRW; Davidson DJ; Rossi AG; Hill AT Chest; 2017 Aug; 152(2):368-378. PubMed ID: 28554732 [TBL] [Abstract][Full Text] [Related]
17. [Chronic bronchial infection: the problem of Pseudomonas aeruginosa]. Cantón R; Fernández Olmos A; de la Pedrosa EG; del Campo R; Antonia Meseguer M Arch Bronconeumol; 2011 Jun; 47 Suppl 6():8-13. PubMed ID: 21703473 [TBL] [Abstract][Full Text] [Related]
18. Microbiological Progress in Patients with Bronchial Infection with Pseudomonas aeruginosa Treated with Nebulised Colistin. Bruguera-Àvila N; Garcia-Olive I; Marin A; Prat C; Lacoma A; Gil M; Abad Capa J Respiration; 2019; 97(6):501-507. PubMed ID: 30605912 [TBL] [Abstract][Full Text] [Related]
19. The contribution of Wang R; Ding S; Lei C; Yang D; Luo H Ann Med; 2021 Dec; 53(1):459-469. PubMed ID: 33754900 [TBL] [Abstract][Full Text] [Related]